Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Jost

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
New Strategies for the Treatment of Atrial FibrillationNorbert Jost, Torsten Christ, János Magyar
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|February 9, 2007
Slow delayed rectifier potassium current (IKs) and the repolarization reserveNorbert Jost, Julius Gy Papp, András Varró
Journal of Polymers and the Environment|February 2, 2021
Polysaccharides; Classification, Chemical Properties, and Future Perspective Applications in Fields of Pharmacology and Biological Medicine (A Review of Current Applications and Upcoming Potentialities)Aiman Saleh A Mohammed, Muhammad Naveed, Norbert Jost
Current Pharmaceutical Design|October 30, 2014
ATP-sensitive potassium channel modulators and cardiac arrhythmias: an updateDanina M Muntean, Loránd Kiss, Norbert Jost, et al.
Progress in Biophysics and Molecular Biology|May 22, 2016
Rabbit models as tools for preclinical cardiac electrophysiological safety testing: Importance of repolarization reserveIstván Baczkó, Norbert Jost, László Virág, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial FibrillationJesús Borrego, Adam Feher, Norbert Jost, et al.
Biochemical and Biophysical Research Communications|March 31, 2005
Silencing the cardiac potassium channel Kv4.3 by RNA interference in a CHO expression systemDiego Cotella, Norbert Jost, Mahesh Darna, et al.
Canadian Journal of Physiology and Pharmacology|September 1, 2015
Novel experimental results in human cardiac electrophysiology: measurement of the Purkinje fibre action potential from the undiseased human heartNorbert Nagy, Tamás Szél, Norbert Jost, et al.
European Journal of Pharmacology|March 15, 2005
Cellular electrophysiological effect of terikalant in the dog heartPéter Biliczki, Károly Acsai, László Virág, et al.
Basic Research in Cardiology|July 8, 2008
Contribution of I Kr and I K1 to ventricular repolarization in canine and human myocytes: is there any influence of action potential duration?Norbert Jost, Károly Acsai, Balázs Horváth, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
New Strategies for the Treatment of Atrial FibrillationNorbert Jost, Torsten Christ, János Magyar
Annals of Noninvasive Electrocardiology : the Official Journal of the International Society for Holter and Noninvasive Electrocardiology, Inc|February 9, 2007
Slow delayed rectifier potassium current (IKs) and the repolarization reserveNorbert Jost, Julius Gy Papp, András Varró
Journal of Polymers and the Environment|February 2, 2021
Polysaccharides; Classification, Chemical Properties, and Future Perspective Applications in Fields of Pharmacology and Biological Medicine (A Review of Current Applications and Upcoming Potentialities)Aiman Saleh A Mohammed, Muhammad Naveed, Norbert Jost
Current Pharmaceutical Design|October 30, 2014
ATP-sensitive potassium channel modulators and cardiac arrhythmias: an updateDanina M Muntean, Loránd Kiss, Norbert Jost, et al.
Progress in Biophysics and Molecular Biology|May 22, 2016
Rabbit models as tools for preclinical cardiac electrophysiological safety testing: Importance of repolarization reserveIstván Baczkó, Norbert Jost, László Virág, et al.
Pharmaceuticals (Basel, Switzerland)|December 28, 2021
Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial FibrillationJesús Borrego, Adam Feher, Norbert Jost, et al.
Biochemical and Biophysical Research Communications|March 31, 2005
Silencing the cardiac potassium channel Kv4.3 by RNA interference in a CHO expression systemDiego Cotella, Norbert Jost, Mahesh Darna, et al.
Canadian Journal of Physiology and Pharmacology|September 1, 2015
Novel experimental results in human cardiac electrophysiology: measurement of the Purkinje fibre action potential from the undiseased human heartNorbert Nagy, Tamás Szél, Norbert Jost, et al.
European Journal of Pharmacology|March 15, 2005
Cellular electrophysiological effect of terikalant in the dog heartPéter Biliczki, Károly Acsai, László Virág, et al.
Basic Research in Cardiology|July 8, 2008
Contribution of I Kr and I K1 to ventricular repolarization in canine and human myocytes: is there any influence of action potential duration?Norbert Jost, Károly Acsai, Balázs Horváth, et al.
Pageof 6